| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Sublingual Immunotherapy |
| Brand | Grazax® |
| Indication | For the Prevention of Seasonal Grass Pollen-Induced Rhinoconjunctivitis. |
| Assessment Process | |
| Rapid review commissioned | 01/09/2007 |
| Rapid review completed | 24/09/2007 |
| Rapid review outcome | Reimbursement not recommended |
The cost-effectiveness of Grazax® remains to be established and this product cannot be recommended as value for money at this point in time.